Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
Antiphospholipid syndrome is characterised by increased neutrophil extracellular trap formation (NETosis) and, consequently, increased thrombotic events. Here Ali et al. show that treatment with adenosine receptor agonists suppresses NETosis and venous thrombosis in mouse models of antiphospholipid...
Guardado en:
Autores principales: | Ramadan A. Ali, Alex A. Gandhi, He Meng, Srilakshmi Yalavarthi, Andrew P. Vreede, Shanea K. Estes, Olivia R. Palmer, Paula L. Bockenstedt, David J. Pinsky, Joan M. Greve, Jose A. Diaz, Yogendra Kanthi, Jason S. Knight |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8ca98b7f1d54784a2dbed7642ccb42a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia
por: José Perdomo, et al.
Publicado: (2019) -
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Katrien M.J. Devreese, et al.
Publicado: (2021) -
SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
por: Nitin Kumar, et al.
Publicado: (2021) -
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Yu Zuo, et al.
Publicado: (2021) -
Netosis in patients with systemic lupus erythematosus
por: V. V. Zhelezko, et al.
Publicado: (2020)